Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea

배종면 2019년
논문상세정보
' Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Immunogenetics
  • Precision medicine
  • Synthetic vaccines
  • hantaanvirus
  • hemorrhagicfeverwithrenalsyndrome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
66 0

0.0%

' Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea' 의 참고문헌

  • Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
    Gaucher D [2008]
  • Vaccinomics, adversomics, and the immune response network theory : individualized vaccinology in the 21st century
    Poland GA [2013]
  • Vaccinology in the third millennium : scientific and social challenges
    Poland GA [2016]
  • Vaccinology in the era of high-throughput biology
    Nakaya HI [2015]
  • Vaccines for the future : learning from human immunology
  • Vaccines for hantaviruses : progress and issues
  • Systems vaccinology for cancer vaccine development
    Petrizzo A [2014]
  • Systems vaccinology : enabling rational vaccine design with systems biological approaches
    Hagan T [2015]
  • Systems vaccinology
    Pulendran B [2010]
  • Systems serology for evaluation of HIV vaccine trials
    Ackerman ME [2017]
  • Systems immunogenetics of vaccines
    Mooney M [2013]
  • Systems biology approaches to new vaccine development
    Oberg AL [2011]
  • Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
    Querec TD [2009]
  • Systems biology approach for cancer vaccine development and evaluation
    Circelli L [2015]
  • Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases
    오수진 [2018]
  • Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome
    Jung J [2018]
  • Protective effectiveness of hantavirus vaccine
    Park K [2004]
  • Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine(Hantavax) : consideration of active immunization in South Korea
    Sohn YM [2001]
  • Personalized vaccines : the emerging field of vaccinomics
    Poland GA [2008]
  • Online library of drugs and foods
  • Milestones in history of adult vaccination in Korea
    Oh MD [2012]
  • Human pathogenic hantaviruses and prevention of infection
    Krüger DH [2011]
  • Heterogeneity in vaccine immune response : the role of immunogenetics and the emerging field of vaccinomics
    Poland GA [2007]
  • Hantaviruses : immunology, treatment, and prevention
    Maes P [2004]
  • Hantavirus infections
  • Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome
    이용진 [2018]
  • Design and interpretation of vaccine field studies
    Halloran ME [1999]
  • A systems framework for vaccine design
    Mooney M [2013]
  • A field efficacy trial of inactivated hantaan virus vaccine(Hantavax(TM))against hemorrhagic fever with renal syndrome(HFRS)in the endemic areas of Yugoslavia from 1996 to 1998
    Chu YK [1999]